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Preemptive Effect of Two Different (Intracuff and Intravenous) Routes of Dexamethasone 
Administration on Postoperative Sore Throat and Cough
INTRODUCTION
Postoperative sore throat, post-extubation cough, and hoarse 
voice are the most common complications of general 
anesthesia produced using endotracheal intubation. The 
incidence of these complications has been reported to be 
between 30% and 81% (1-4). In addition, the incidence of 
postoperative sore throat is between 14.4% and 50% (5, 6). 
These complications lead to anxiety and dissatisfaction in 
patients after surgery (7). In order to minimize the incidence 
and severity of these complications, various methods such as 
licorice gargle, fluticasone propionate inhalation, aspirin 
and benzydamine hydrochloride gargle, lidocaine spray, 
intracuff diluted lidocaine, magnesium, stellate ganglion 
block, and Dexamethasone and lidocaine injection have 
been used for controlling complications (4, 7-9). Despite 
their efficiency in reducing postoperative airway symptoms, 
these methods cause the same complications in patients due 
to their limited accessibility (8). The cuffed tracheal tube, 
lubricants used on the tracheal tube, cuff pressure, and 
various other factors can affect the incidence and severity of 
postoperative sore throat and cough (10). The etiology of 
postoperative cough is partially attributed to the stimulation 
and inflammation of mucus and airway mucus induced by 
tracheal tube; therefore, local anesthesia of mucus secretion 
increases the tolerance of tracheal tube during its contact 
with mucus (11). The administration of intravenous 
Dexamethasone is simple, effective, and available in the 
operating room. Preemptive Dexamethasone administration 
before anesthetic induction decreases the severity of postop-
erative sore throat (12, 13). In addition, the efficacy of 
intravenous Dexamethasone in reducing the probability of 
occurrence and severity of postoperative airway symptoms 
has been well-documented (14). Hitherto, the effect of 
intravenous and intracuff Dexamethasone administration on 
postoperative sore throat and cough has been assessed. 
However, since the preemptive effect of the two different 
routes of Dexamethasone administration (i.e., intravenous 
and intracuff) has been compared in only a few studies, the 
present study aimed to provide further insights with respect 
to the preemptive effect.
Introduction: The most common complications following anesthesia intubation 
include postoperative sore throat, post-extubation cough, and hoarse voice. Currently, 
the use of preoperative Dexamethasone has been effective in controlling these complica-
tions. Therefore, the present study aimed to compare the preemptive effect of intracuff 
and intravenous routes of Dexamethasone administration for postoperative sore throat 
and cough. Materials and Methods: In the present clinical trial, 96 patients who under-
went general anesthesia intubation were randomly assigned to three groups. The first 
group received 4 mg intracuff Dexamethasone, the second group received 4 mg intrave-
nous Dexamethasone, and the third group was administered a placebo. Cough frequen-
cy and severity of a sore throat after extubation were investigated in the three groups. 
Results: Any significant difference was not observed among the three groups regarding 
hemodynamic variables (P>0.01); however, the incidence of cough was significantly 
lower in all the three groups (P<0.01). Also, the average severity of a sore throat in 
PAR and 1 h after surgery in the three groups was significantly lower (P<0.05). Moreo-
ver, no difference was detected in the groups regarding the severity of a sore throat 
within 24 h post-surgery (P>0.01). Conclusion: The use of two methods of intravenous 
and intracuff Dexamethasone administration before surgery reduced the incidence of 
postoperative cough and the severity of sore throat in patients.
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In the present study, since the patients fulfilled the inclusion 
criteria, none were excluded from the study. The patients 
were divided into three groups: the first was intracuff group 
(14 females and 18 males), the second was an intravenous 
group (15 females and 17 females), and the third was control 
group (17 males and 15 females). No significant difference 
was detected among the groups with respect to demographic 
information such as age and gender (P> 0.05). In addition, 
no significant difference was observed between groups 
regarding systolic blood pressure, diastolic pressure, and 
heart rate before anesthesia, 3 min and 15 min after tracheal 
intubation, and 3 min after tracheal extubation (P>0.05). 
However, according to the repeated measure ANOVA, 
changes in systolic and diastolic blood pressure and heart 
rate were significant in the three groups at the time points 
mentioned above (P<0.001). Moreover, no significant 
difference was observed among the groups regarding the 
intubation time (P=0.68) (Table 1).
     The incidence of patient’s cough was recorded by the 
nurse in PAR; it was significantly lower in the first, second, 
RESULTS
This randomized, double-blind, clinical trial was performed 
on 96 patients who visited Al-Zahra Hospital in 2017-2018 
and received general anesthesia using intubation and 
laryngoscopy. The inclusion criteria were as follows: 
patients were given general anesthesia by intubation and 
laryngoscopy, age range 18–65 years, ASA score 1 and 2, 
mouth openness >3.5 cm, and consent to participate in the 
study. Patients with a preoperative sore throat, asthma, 
hoarse voice, history of respiratory tract infection or sore 
throat in 2 weeks before surgery, history of cigarette 
smoking, history of taking analgesics or steroids in 12 h 
before surgery, and allergic to Dexamethasone were not 
included in the study. The patients were also excluded if the 
duration of the operation lasted for >300 min, more than one 
attempt was made for tracheal intubation, the method of 
anesthesia was altered for any reason, and the patient 
required postoperative mechanical ventilation in the 
intensive care unit.
   After random selection using Random Allocation 
Software, the patients were divided into three groups: 
Groups 1, 2 and 3. In Group 1, before intubation, 4 mg 
intracuff Dexamethasone was administered in order to 
moisten the tracheal cuff wall. During intubation, it was 
reloaded into the sterilized syringe, and after intubation, it 
was re-injected into the cuff. Moreover, 4 mg intravenous 
normal saline was administered to the patient (15). In Group 
2, before intubation, 4 mg Dexamethasone was administered 
intravenously to the patient, and 4 mg saline was injected 
into the tracheal tube cuff. During intubation, it was reload-
ed into the sterile syringe, and after intubation, it was again 
injected into the tracheal cuff (16). In Group 3 or placebo 
group, before intubation, the tracheal cuff wall was 
moistened with normal saline; in addition, 4 mg intravenous 
normal saline was administered. Notably, the anesthesiolo-
gist, surgeon, and person collecting information were 
unaware of the implementation of this study, and Dexametha-
sone and normal saline were numbered in pre-filled syringes 
and provided to the anesthesiologist.
      The anesthetic induction method was the same in the 
three groups. Tracheal intubation was performed through the 
mouth and after the anesthesiologist ensured adequate 
muscle relaxation for tracheal intubation. Supa cuffed trache-
al tube (with high-volume low-pressure cuff) with an 
internal diameter of 8-7 mm was used for tracheal intuba-
tion. The cuff pressure was maintained at 20 cm of water 
using a special manometer. Finally, surgical muscle relaxa-
tion was treated with atropine 0.02 mg/kg and neostigmine 
0.04 mg/kg. On complete awakening, the patient was 
extubated and transferred to post-anesthesia care unit 
(PACU).
       In this study, hemodynamic changes in the patients 
including systolic and diastolic blood pressure and heart rate 
at 4 different time points in perioperative period, i.e., before 
anesthesia, 3 min after tracheal intubation, 15 min after 
tracheal intubation, and 3 min after the tracheal extubation 
was measured by a third person (nurse) who was unaware of 
the study. At the end of the surgery, trachea suction was 
performed slowly on the patient, and the tracheal tube was 
removed after the cuff deflation, and the patient had 
adequate pulmonary ventilation with arterial oxygen satura-
tion >95%. The tracheal intubation time (from intubation to 
extubation) was also measured and recorded by a third 
person (nurse). Also, the duration, the start, and end time of 
the operation were recorded.
       The incidence of cough frequency after tracheal extuba-
tion was recorded in PAR via observation by a third person 
(nurse) who was unaware of the drug type administered to 
the patient. In this study, the severity of sore throat was 
recorded via the visual analog scale (VAS) and by the patient 
at the time he was in PACU, and after 1 and 24 h. In the VAS 
scale, 0 indicates the lack of sore throat and 10 indicates 
severe sore throat. Moreover, the patient scored his sore 
throat within the range of 0–10. Moreover, Dexamethasone 
side effects such as psychiatric disorders, blurry vision, and 
digestive disorder were also documented by a third person 
(nurse). 
      Statistical analysis: The confidence level and power of 
statistical test were 0.95 and 0.80, respectively, for 
z_(1-α/2). Moreover,〖 z〗_(1-β) from standard normal 
distribution is 1.96 and 0.84, respectively, and ES indicates 
Cohen’s effect size, which is 0.7 in the present study. There-
fore, the sample size was 32 patients in each group. Data 
were collected and entered into SPSS 22. Chi-Square and 
one-way ANOVA tests were used to compare the groups. 
Moreover, repeated measure ANOVA was used to determine 
the changes in data at different time points. P-value<0.05 
was considered as statistically significant.
(43.8%) 14
(56.3%) 18
(53.1%) 17 0.58
(46.9%) 15
Abbreviations; min: minute, SD: standard deviation, mm Hg:  millimeters of mercury
Variable Group 2Group 1 Placebo P-value
Gender Male
Female 
55.46±11.59
77.87±19.17
78.75±17.50
72.15±13.43
61.15±16.36
58.43±16.67 0.68
74.96±11.93
77.25±16.21
69.81±18.54
57.87±13.50
Duration of anesthesia with intubation 
(min) (mean±SD)
Before anesthesia
3 min after intubation
15 min after intubation
123.90±25.43
127.61±26.84
117.96±31.24
115.69±31.14
116.38±21.19 0.43
118.48±13.94
110.46±19.87
108.74±18.69
0.12
0.25
0.53
0.67
0.52
0.23
0.57
(56.3%) 18
(43.8%) 14
57.03±12.23
74.37±17.91
81.87±15.99
76.34±13.63
61.53±15.75
119.64±22.30
128.58±18.86
121.13±22.20
114.27±20.30
Systolic blood pressure 
(mmHg) (mean± SD)
Diastolic blood pressure 
(mmHg) (mean±SD)
Before anesthesia
3 min after intubation
15 min after intubation
3 min after extubation
82.62±17.67 80.37±15.75Before anesthesia 0.8781.53±18.01Heart rate (n/min) 
(mean±SD)
3 min after extubation
89.06±16.83
87.12±17.60
85.56±18.45
85.68±17.16
84.75±18.05
84.28±18.21
3 min after intubation
15 min after intubation
0.54
0.85
0.90
90.50±19.20
86.81±18.75
86.34±18.473 min after extubation
Table 1. Demographic and clinical information of patients in three groups
(9.4%) 3 (34.4%) 11 0.03
Abbreviations; VAS: visual analog scale, SD: standard deviation
Variable Group 2Group 1 Placebo P-value
Frequency 
of cough in recovery
Male
4.09±1.32
2.12±1.31
0.34±0.78
6.65±2.13 0.001>
5.84±2.03
0.78±1.18
0.001>
0.15
(15.6%) 5
5.25±2.32
3.46±1.95
0.40±0.91
VAS 
(mean± SD)
Immediate after entry in recovery
1 h later
24 h later
Table 2. Frequency of cough and sore throat 
3
Based on the results of this study and given the effect of 
intravenous and intracuff Dexamethasone administration on 
hemodynamic variables, no difference was detected between 
the two methods of administration. The frequency of cough 
and the severity of sore throat in the groups with intravenous 
and intracuff. Dexamethasone administration were less than 
those in the placebo group. Typically, both intravenous and 
intracuff methods are effective and did not exhibit severe 
side effects in controlling postoperative sore throat and 
cough in patients undergoing general anesthesia with intuba-
tion. Studies have examined intravenous and intracuff 
methods of Dexamethasone administration in postoperative 
cough, but none of the studies have compared these two 
methods. To the best of our knowledge, this is the first study 
to compare intravenous and intracuff Dexamethasone admin-
istration along with a placebo group. Some results of the 
DISCUSSION 
 and control groups (P=0.03), respectively. The mean of sore 
throat severity or VAS was significantly lower in the first, 
second, and placebo groups in PAR and 1 h after the 
operation (P<0.05). However, no significant difference was 
detected among groups in terms of VAS at 24 h after the 
operation (P=0.15). According to the repeated measure 
ANOVA, changes in VAS were significant at all time points 
in the three groups (P<0.001); no adverse side effects were 
observed in the groups in this study (Table 2).
Dexamethasone Administration on Postoperative Sore Throat and Cough
4According to the results of this study, the use of two methods 
of preoperative intravenous and intracuff Dexamethasone 
reduced the amount of postoperative cough and the severity 
of sore throat in patients. Moreover, these methods do not 
have a significant effect on hemodynamic variables and do 
not cause severe side effects. Nevertheless, this study had 
some limitations, such as lack of a specific criterion for 
assessing the severity of the cough. Therefore, additional 
studies with larger sample size are needed to substantiate the 
current findings.
CONCLUSION
study by Lee et al. were consistent while some were 
inconsistent with our findings. Lee et al. examined the effect 
of intravenous 0.1 and 0.2 mg Dexamethasone on the 
incidence of preoperative sore throat. They concluded that 6 
and 24 h after extubation, the incidence of sore throat in the 
group receiving 0.1 mg/kg/h Dexamethasone was less than 
the group receiving 0.2 mg/kg. They also found that the 
incidence of sore throat was less in both groups than that in 
the placebo group.
     Moreover, only a small number of subjects that received 
0.1 and 0.2 mg/kg Dexamethasone had an average (moder-
ate) sore throat severity at 1 and 24 h post-extubation. The 
incidence of hoarse voice at 1, 6, and 24 h after extubation 
was significantly lower in the group receiving 0.2 mg/kg 
Dexamethasone than in the placebo group. However, no 
significant difference was detected among the three groups 
regarding the incidence of postoperative cough (6). Kim et 
al. examined the effect of Dexamethasone (10 mg intrave-
nous administration) as prophylaxis for the reduction of 
postoperative sore throat in 70 patients. They concluded that 
1 and 6 h after the surgery, the mean score of postoperative 
sore throat severity in the group that received Dexametha-
sone before surgery was significantly lower than those who 
received Dexamethasone after intubation. However, no 
significant difference was detected regarding the score of 
sore throat between the two groups at 24 h after surgery (2). 
In another study consistent with the present study, 8 mg 
intravenous Dexamethasone was used, and the incidence of 
sore throat in the Dexamethasone group was significantly 
lower (22.4%) than that in the control group (57.5%) at 24 h. 
Moreover, the severity of postoperative sore throat based on 
VAS at 1, 3, 6, 12, and 24 h after surgery was significantly 
lower in the Dexamethasone group than in the control group 
(17). Some studies were conducted to study the effect of 
Dexamethasone and lidocaine combination on the complica-
tions of intubation after surgery. The study by Refiei et al. 
was inconsistent with the current study as it compared three 
drugs of intracuff saline, Dexamethasone, and lidocaine 
with respect to the complications of intubation. Consequent-
ly, a difference was noted among the three groups of drugs 
regarding the incidence and the severity of cough, and 
lidocaine reduced the incidence of cough while Dexametha-
sone reduced the severity of the cough. Moreover, no signifi-
cant difference was detected among the groups regarding the 
hemodynamics (15). The study by Ruangsin et al., which is 
inconsistent with the current study, reported that intravenous 
Dexamethasone did not exert a significant effect on postoper-
ative sore throat (18). 
     Another study that was consistent with the present study 
concluded that both intracuff lidocaine and Dexamethasone 
significantly reduce postoperative sore throat and cough 
(19). The study by Choubsaz et al., which was inconsistent 
with our study, examined the effect of adding Dexametha-
sone to 2% lidocaine on the reduction of postoperative 
complications after general anesthesia. In the present study, 
the patients were divided into four groups: the first group 
received 2% lidocaine, the second group received 4 mg 
Dexamethasone, the third group received 2% lidocaine and 
4 mg Dexamethasone, and the fourth was placebo group. 
Based on the results of the study, a significant difference was 
detected in the heart rate among the Dexamethasone and 
Dexamethasone-lidocaine with the placebo groups. In 
addition, the heart rate in the Dexamethasone group and 
Dexamethasone-lidocaine group was significantly lower 
than that in the placebo group. Moreover, a significant 
difference was observed in the sore throat among the groups, 
and the incidence of sore throat in the Dexamethasone-lido-
caine group was higher than that in the other groups, while 
that in the lidocaine group was lower than that in the other 
groups. Also, Dexamethasone does not affect the reduction 
in postoperative respiratory complications (10).
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